November 2024 - Cancer Currents Blog
-
Trial Results Support SBRT as a Standard Option for Some Prostate Cancers
In a trial, men who received stereotactic body radiotherapy (SBRT) didn’t have a higher risk of cancer recurrence than men treated with other common radiation therapy regimens that are given over longer periods.
-
How Do Black People with Cancer View Clinical Research?
Black people with cancer are much less likely to join clinical trials than White patients. Results from a new study may help explain why and help research staff talk with and recruit more Black participants.
-
Nivolumab Appears to Boost Cure Rate in Advanced Hodgkin Lymphoma
In a nearly 1,000-patient trial, treatment with nivolumab (Opdivo) and the chemotherapy regimen AVD was better at eliminating cancer and keeping it at bay than the current standard initial treatment for the disease, AVD and brentuximab (Adcetris). The nivolumab combination also had fewer side effects.
-
Bladder Cancer Trial Finds Extended Lymph Node Surgery Doesn’t Improve Survival
A randomized clinical trial comparing two types of surgery in people with localized muscle-invasive bladder cancer found that more extensive surgery removing a larger group of lymph nodes did not improve survival, compared with standard lymph node surgery.
-
New on NCI’s Websites for November 2024
NCI periodically provides updates on new websites and other online content of interest to the cancer community. See selected content that has been added as of November 1, 2024.